| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.81B | -17.1% |
| Cost of Revenue | $480.9M | -34.5% |
| Gross Profit | $1.33B | -8.3% |
| R&D Expense | $924.8M | -12.2% |
| SG&A Expense | $410.1M | +3.0% |
| Operating Income | -$755.1M | +9.3% |
| Pre-tax Income | -$667.1M | +16.4% |
| Income Tax | -$2.8M | -110.0% |
| Net Income | -$664.1M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.52B | -4.6% |
| Accounts Receivable | $573.9M | -6.2% |
| Current Assets | $2.23B | -4.3% |
| Total Assets | $6.74B | -7.0% |
| Current Liabilities | $889.5M | -0.5% |
| Total Liabilities | $3.31B | -13.5% |
| Stockholders' Equity | $3.19B | +0.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $315.6M | +34.4% |
| Capital Expenditures | $29.5M | -47.2% |
| Investing Cash Flow | -$42.4M | -196.3% |
| Financing Cash Flow | -$338.3M | -94.4% |
| Free Cash Flow | $286.0M | +60.0% |
| +19.2% |
| EPS (Basic) | -$1.68 | +22.2% |
| EPS (Diluted) | -$1.68 | +22.2% |